Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update

Go back to Xenon Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update
(NASDAQ: XENE) Delayed: 59.55 --0 (-0%)
Previous Close $59.55    52 Week High $9.75 
Open $59.55    52 Week Low $5.65 
Day High $59.55    P/E N/A 
Day Low $59.55    EPS $0.00 
Volume 1,583